The Telehealth Economy
The platforms, the pharmacies, and the policy that shape how patients actually access these drugs.
Telehealth is now the front door for tens of millions of prescriptions. This desk follows the business models, the FDA enforcement, the insurance picture, and the policy arc that will shape who can access these medications in the next five years — and under what terms.
This Week's Feature
How the GLP-1 Telehealth Boom Happened
Blockbuster trial results, a $1,000-a-month price wall, and a drug-shortage loophole combined to move some of the most in-demand prescriptions in America onto telehealth websites — until the loophole closed.
Read the feature →
The Telehealth Economy Getting a GLP-1 Prescription Online: What to Know
Telehealth companies now offer these weight-loss medicines after a short online form. Here is what FDA labeling, the major trials, and clinical guidelines actually say — and how to spot a risky service.
The Telehealth Economy The End of the GLP-1 Shortage — and What It Means
The FDA says the shortages of the blockbuster weight-loss drugs are over. That decision reshapes who can legally make them, where the telehealth market goes next, and what is actually known about the copies.